Understanding how a specific protein affects brain development and function
Role of DYT6 Dystonia Protein THAP1 in Oligodendroglial Mediated ECM Homeostasis During CNS Development
This study is looking at how a specific protein related to DYT6 dystonia helps keep the brain's support system healthy during development, which could help us understand more about dystonia and similar brain conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11231925 on NIH RePORTER |
What this research studies
This research investigates the role of the DYT6 dystonia protein THAP1 in maintaining the balance of the brain's extracellular matrix (ECM) during central nervous system (CNS) development. It focuses on how glial cells and the ECM influence the differentiation of oligodendrocyte progenitor cells into myelinating oligodendrocytes, which are crucial for proper brain function. By using genetic tools to manipulate ECM metabolism, the study aims to uncover mechanisms that could lead to improved understanding of dystonia and other neurodevelopmental disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with dystonia or other neurodevelopmental disorders related to myelination and ECM dysfunction.
Not a fit: Patients without any neurological disorders or those not affected by dystonia may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for dystonia and related neurodevelopmental disorders.
How similar studies have performed: Previous research has shown promising results in understanding the role of ECM in brain development, suggesting that this approach could yield valuable insights.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Yellajoshyula, Dhananjay — Case Western Reserve University
- Study coordinator: Yellajoshyula, Dhananjay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.